InsidersTradesSigma
Discover the complete record of transactions filed by Min Kwan-Hong Christopher, Directeur Médical. Director active across 1 companies, notably Longeveron Inc.. Cumulatively, 2 reports have been published. The latest transaction was disclosed on 4 April 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Christopher Kwan-Hong Min is the Chief Medical Officer at Longeveron Inc. He is responsible for medical strategy and product development. Christopher plays a key role in innovation and improving healthcare. His expertise in medicine and clinical research is essential for Longeveron's success.